Small Business Innovation Research · Small Business Technology Transfer
Affinergy, LLC: SBIR & STTR awards
75 awards worth $59.80M to 1 companies since 2005 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Affinergy, LLC's federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2023 | 0 | 1 | $1.20M |
| 2021 | 1 | 1 | $1.72M |
| 2020 | 2 | 1 | $2.55M |
| 2019 | 3 | 2 | $5.24M |
| 2018 | 4 | 1 | $3.50M |
| 2017 | 3 | 2 | $4.39M |
| 2016 | 3 | 1 | $2.24M |
| 2015 | 2 | 1 | $2.85M |
| 2014 | 7 | 1 | $3.98M |
| 2012 | 2 | 4 | $7.82M |
| 2011 | 2 | 1 | $2.51M |
| 2010 | 2 | 1 | $2.43M |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| A novel peptide assay for hepcidin clinical monitoring · topic 400 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.20M | 2023-08-01 |
| A Rapid Point of Care Test for APOL1 Renal Risk Alleles · topic NIMHD | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.43M | 2021-07-01 |
| Novel clinical assay to rapidly monitor posaconazole levels in plasma · topic NIAID | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $294.5K | 2021-04-02 |
| Immunoprofiling to develop a novel diagnostic array for cardiac sarcoidosis · topic NHLBI | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $299.8K | 2020-06-20 |
| Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients · topic 400 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.95M | 2020-05-01 |
| Development of a peptide-based diagnostic for amyotrophic lateral sclerosis · topic NINDS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $299.8K | 2020-01-15 |
| Development of a multiplex point-of-care assay to identify patients with Venous Thromboembolism · topic NHLBI | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $297.4K | 2019-09-01 |
| Novel assay to monitor Tacrolimus levels at the point of care · topic NIAID | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.23M | 2019-08-01 |
| Development of a novel clinical assay for measuring everolimus levels · topic NIAID | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.11M | 2019-05-21 |
| Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients · topic 400 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $283.2K | 2019-05-01 |
| Development of a multiplex peptide array to identify patients with an autoantibody signature for chronic pain · topic NIDA | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $320.1K | 2019-03-01 |
| Point-of-care device to identify patients at risk for preeclampsia · topic N | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.28M | 2018-09-24 |
| A novel clinical assay for detection of APOL1 renal risk alleles · topic 102 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $320.0K | 2018-09-18 |
| Novel assay to monitor Tacrolimus levels at the point of care · topic NIAID | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2018-06-15 |
| Autoantibody profiling to develop a novel diagnostic array for systemic sclerosis · topic NIAID | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $299.2K | 2018-05-01 |
| A point-of-care assay to monitor tobramycin in cystic fibrosis patients · topic NHLBI | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $299.6K | 2018-04-01 |
| Novel PhageLock assay to measure hepcidin for clinical monitoring · topic 400 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $333.0K | 2017-09-16 |
| Novel technologies for detection of podocytes from preeclamptic patients · topic NICHD | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.00M | 2017-09-11 |
| Point of care device to identify patients at risk for preeclampsia · topic NIBIB | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $252.2K | 2017-08-07 |
| Stem cell-binding peptides for rapid fixation of total hip replacements · topic NIAMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.50M | 2017-08-03 |
| Peptide based tool for the rapid isolation of quiescent monocytes from peripheral blood · topic 102 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $308.8K | 2017-03-09 |
| Novel technologies for the detection of podocytes from preeclamptic patients · topic NICHD | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2016-09-22 |
| Peptide-based slides for improving the diagnostic quality of sputum specimens · topic 102 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2016-09-16 |
| Phage based assay to measure daptomycin concentration in biological fluids · topic 300 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.34M | 2016-09-01 |
| Novel technologies for improved slide quality of pancreatic fine-needle aspirates · topic 300 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $301.0K | 2016-07-01 |
| Novel technologies to remove obscuring blood from fine needle aspiration biopsies · topic NIGMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.30M | 2015-06-01 |
| Beta-2 Microglobulin Depletion Columns for Amyloidosis Prevention and Treatment · topic NHLBI | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $293.8K | 2015-04-01 |
| Phage-based assay to measure daptomycin concentration in biological fluids · topic 300 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $257.0K | 2015-02-01 |
| Peptide-coated skin substitutes for the treatment of burn injuries and wounds · topic 300 | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.11M | 2014-09-15 |
| Novel technology to remove obscuring blood from fine needle aspiration biopsies · topic NIGMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $304.8K | 2014 |
| Affinity Capture Peptides for Clinical Mass Spectrometric Assays in Plasma · topic NIGMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $283.8K | 2014 |
| Peptide-mediated apheresis for inflammatory bowel diseases · topic NIDDK | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $280.8K | 2014 |
| Peptide-mediated attachment of non-plateable hepatocytes to surfaces · topic NIDDK | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $280.5K | 2014 |
| Development of a novel clinical assay for measuring serum hepcidin levels · topic NIDDK | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $276.2K | 2014 |
| Stem cell therapy for improved fixation of cementless total hip replacements · topic NIAMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $224.7K | 2014 |
| High-viability cryopreservation media for primary hepatocytes · topic NIDDK | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $224.4K | 2014 |
| Development of an adipose-derived stem cell isolation matrix · topic NIGMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $2.38M | 2012 |
| Delivery of Adipose Derived Stem Cells for Healing Surgical Hernia Repairs · topic NIGMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.82M | 2012 |
| Bioactive Peptide Coatings for Synthetic Bone Grafts · topic NIGMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.68M | 2012 |
| Peptide conjugation for Co-Delivery of Growth Factors and Stem Cells · topic NIGMS | Affinergy, LLC · North Carolina | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.48M | 2012 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.